News Releases

Ludwig Scientist Bing Ren elected Fellow of the American Association for the Advancement of Science

November 25, 2013, New York, NY—Ludwig scientist Bing Ren has been named a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society. Election as a fellow is an honor bestowed upon AAAS members by their peers.

AAAS lauded Ren for his outstanding original contributions to the analysis of genome wide distributions of regulatory factors, transcriptional regulatory sequences and of the large scale organization of eukaryotic genomes. His research focuses on the growing understanding of the workings of the human genome and how to use that data to change the course of disease. His work has been at the forefront of mapping human DNA to yield the invaluable data needed to understand the genetic drivers of disease.

Ren received his PhD training in gene regulation from Tom Maniatis, PhD at Harvard University, then extended his research in genomics and global analysis of gene expression by working as a postdoctoral fellow in the lab of Richard Young, PhD at Whitehead Institute. During this time he developed the ChIP-chip technology for studying in vivo transcription factor binding and chromatin modification states.

Since 2001, he has been a member of the Ludwig Institute for Cancer Research and a faculty member of the University of California, San Diego School of Medicine. His research is focused on genomic and epigenomic analyses of human embryonic stem cell differentiation and mammalian development. He has directed a Roadmap Epigenome Project to produce reference human epigenome maps since 2008. He is currently leading an ENCODE production project to annotate the mammalian transcriptional regulatory sequences.

This year a total of 388 AAAS members were awarded the distinction of Fellow. The new Fellows will be officially welcomed on Saturday, February 15, 2014, at the AAAS Annual Meeting in Chicago. The official announcement of their election will appear in the AAAS News & Notes section of the journal Science on November 29, 2013.

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists with a 40-year legacy of pioneering cancer discoveries. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $1.6 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Bing Ren is a member of the Ludwig Institute for Cancer Research who is based at the University of California, San Diego.


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?